{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:47:26Z","timestamp":1792273646326,"version":"4.4.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004954","name":"Augustinus Fonden","doi-asserted-by":"publisher","award":["23-2425"],"award-info":[{"award-number":["23-2425"]}],"id":[{"id":"10.13039\/501100004954","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Copenhagen University","id":[{"id":"https:\/\/ror.org\/035b05819","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00198-026-08035-0","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T22:13:56Z","timestamp":1776896036000},"page":"1991-2003","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Parathyroid hormone and alkaline phosphatase are associated with fracture risk in non-dialysis-dependent chronic kidney disease"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2505-2874","authenticated-orcid":false,"given":"C. S. H.","family":"Pichat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. L. F.","family":"Ballegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. O.","family":"Bressendorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. S.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"8035_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaf147","author":"SK Jensen","year":"2025","unstructured":"Jensen SK, Bertelsen M, Vestergaard SV, N\u00f8rgaard M, Thomsen RW, Birn H et al (2025) Occurrence and prognosis of chronic kidney disease in Denmark \u2013 a nationwide population-based cohort study. Clin Kidney J. https:\/\/doi.org\/10.1093\/ckj\/sfaf147","journal-title":"Clin Kidney J"},{"key":"8035_CR2","doi-asserted-by":"publisher","unstructured":"Ketteler M, Evenepoel P, Holden RM, Isakova T, J\u00f8rgensen HS, Komaba H et al (2025) Chronic kidney disease-mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. https:\/\/doi.org\/10.1016\/j.kint.2024.11.013","DOI":"10.1016\/j.kint.2024.11.013"},{"issue":"10","key":"8035_CR3","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1093\/NDT\/GFW073","volume":"31","author":"D Hansen","year":"2016","unstructured":"Hansen D, Olesen JB, Gislason GH, Abrahamsen B, Hommel K (2016) Risk of fracture in adults on renal replacement therapy: a Danish national cohort study. Nephrol Dial Transplant 31(10):1654\u20131662. https:\/\/doi.org\/10.1093\/NDT\/GFW073","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"8035_CR4","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/jbmr.4258","volume":"36","author":"L Folkestad","year":"2021","unstructured":"Folkestad L, Stochholm K, Groth K, Hove H, Andersen NH, Gravholt CH (2021) Fracture rates and fracture risk in patients with Marfan syndrome: a nationwide register-based cohort study. J Bone Miner Res 36(5):901\u2013909. https:\/\/doi.org\/10.1002\/jbmr.4258","journal-title":"J Bone Miner Res"},{"issue":"11","key":"8035_CR5","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/ndt\/gfz142","volume":"35","author":"B Runesson","year":"2020","unstructured":"Runesson B, Trevisan M, Iseri K, Qureshi AR, Lindholm B, Barany P et al (2020) Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine Measurement project. Nephrol Dial Transplant 35(11):1908\u201315. https:\/\/doi.org\/10.1093\/ndt\/gfz142","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"8035_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/MNH.0b013e32832c2264.Parathyroid","volume":"176","author":"J Prochaska","year":"2016","unstructured":"Prochaska J, Benowitz N (2016) Parathyroid hormone signaling in bone and kidney. Physiol Behav 176(1):100\u2013106. https:\/\/doi.org\/10.1097\/MNH.0b013e32832c2264.Parathyroid","journal-title":"Physiol Behav"},{"issue":"1","key":"8035_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2007","unstructured":"Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA et al (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71(1):31\u20138. https:\/\/doi.org\/10.1038\/sj.ki.5002009","journal-title":"Kidney Int"},{"issue":"1","key":"8035_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4158\/EP.14.1.18","volume":"14","author":"DL Andress","year":"2008","unstructured":"Andress DL, Coyne DW, Kalantar-Zadeh K, Molitch ME, Zangeneh F, Sprague SM (2008) Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease. Endocr Pract 14(1):18\u201327. https:\/\/doi.org\/10.4158\/EP.14.1.18","journal-title":"Endocr Pract"},{"issue":"1","key":"8035_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"Supplements KI","year":"2017","unstructured":"Supplements KI (2017) KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone\u00a0disorder (CKD-MBD). Kidney Int Suppl (2011) 7(1):1\u201359. https:\/\/doi.org\/10.1016\/j.kisu.2017.04.001","journal-title":"Kidney Int Suppl (2011)"},{"key":"8035_CR10","doi-asserted-by":"crossref","unstructured":"Ganesh SK, Stack AG, Levin NW, Hulbert-shearon T, Port FK (2001) Association of elevated serum PO 4 , Ca PO 4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","DOI":"10.1681\/ASN.V12102131"},{"issue":"4 SUPPL. 4","key":"8035_CR11","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1053\/j.ajkd.2008.11.029","volume":"53","author":"R Bhuriya","year":"2009","unstructured":"Bhuriya R, Li S, Chen SC, McCullough PA, Bakris GL (2009) Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the kidney early evaluation program (KEEP). Am J Kidney Dis 53(4 SUPPL. 4):S3-10. https:\/\/doi.org\/10.1053\/j.ajkd.2008.11.029","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"8035_CR12","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s00198-019-05033-3","volume":"30","author":"S Geng","year":"2019","unstructured":"Geng S, Kuang Z, Peissig PL, Page D, Maursetter L, Hansen KE (2019) Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease. Osteoporos Int 30(10):2019\u20132025. https:\/\/doi.org\/10.1007\/s00198-019-05033-3","journal-title":"Osteoporos Int"},{"key":"8035_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144855","author":"S Vimalraj","year":"2020","unstructured":"Vimalraj S, Elsevier B.V. (2020) Alkaline phosphatase: structure, expression and its function in bone mineralization. Gene. https:\/\/doi.org\/10.1016\/j.gene.2020.144855","journal-title":"Gene"},{"key":"8035_CR14","doi-asserted-by":"publisher","unstructured":"Haarhaus M, Cianciolo G, Barbuto S, La Manna G, Gasperoni L, Tripepi G, MDPI et al (2022) Alkaline phosphatase: an old friend as treatment target for cardiovascular and mineral bone disorders in chronic kidney disease. Nutrients. https:\/\/doi.org\/10.3390\/nu14102124","DOI":"10.3390\/nu14102124"},{"issue":"5","key":"8035_CR15","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1053\/j.ajkd.2021.07.027","volume":"79","author":"HS J\u00f8rgensen","year":"2022","unstructured":"J\u00f8rgensen HS, Behets G, Viaene L, Bammens B, Claes K, Meijers B et al (2022) Diagnostic accuracy of noninvasive bone turnover markers in renal osteodystrophy. Am J Kidney Dis 79(5):667-676.e1. https:\/\/doi.org\/10.1053\/j.ajkd.2021.07.027","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"8035_CR16","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/ndt\/gfu055","volume":"29","author":"Y Maruyama","year":"2014","unstructured":"Maruyama Y, Taniguchi M, Kazama JJ, Yokoyama K, Hosoya T, Yokoo T et al (2014) A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan. Nephrol Dial Transplant 29(8):1532\u20138. https:\/\/doi.org\/10.1093\/ndt\/gfu055","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"8035_CR17","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/ki.2008.248","volume":"74","author":"MJ Blayney","year":"2008","unstructured":"Blayney MJ, Pisoni RL, Bragg-Gresham JL, Bommer J, Piera L, Saito A et al (2008) High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death. Kidney Int 74(5):655\u201363. https:\/\/doi.org\/10.1038\/ki.2008.248","journal-title":"Kidney Int"},{"issue":"4","key":"8035_CR18","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ekir.2024.01.002","volume":"9","author":"S Yamamoto","year":"2024","unstructured":"Yamamoto S, J\u00f8rgensen HS, Zhao J, Karaboyas A, Komaba H, Vervloet M et al (2024) Alkaline Phosphatase and Parathyroid Hormone Levels: International Variation and Associations With Clinical Outcomes in the DOPPS. Kidney Int Rep 9(4):863\u201376. https:\/\/doi.org\/10.1016\/j.ekir.2024.01.002","journal-title":"Kidney Int Rep"},{"issue":"6","key":"8035_CR19","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.2215\/CJN.08621209","volume":"5","author":"M Abramowitz","year":"2010","unstructured":"Abramowitz M, Muntner P, Coco M, Southern W, Lotwin I, Hostetter TH et al (2010) Serum alkaline phosphatase and phosphate and risk of mortality and hospitalization. Clin J Am Soc Nephrol 5(6):1064\u201371. https:\/\/doi.org\/10.2215\/CJN.08621209","journal-title":"Clin J Am Soc Nephrol"},{"key":"8035_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13387-z","author":"Y Fan","year":"2017","unstructured":"Fan Y, Jin X, Jiang M, Fang N (2017) Elevated serum alkaline phosphatase and cardiovascular or all-cause mortality risk in dialysis patients: A meta-Analysis. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-017-13387-z","journal-title":"Sci Rep"},{"key":"8035_CR21","doi-asserted-by":"publisher","unstructured":"Maruyama Y, Nakashima A, Abe M, Hanafusa N, Nakai S, Yokoo T (2024) Higher serum alkaline phosphatase is risk for death and fracture a nationwide cohort study of Japanese dialysis patients. Kidney360. https:\/\/doi.org\/10.34067\/KID.0000000656","DOI":"10.34067\/KID.0000000656"},{"issue":"4","key":"8035_CR22","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1053\/J.AJKD.2013.04.012","volume":"62","author":"JJ Taliercio","year":"2013","unstructured":"Taliercio JJ, Schold JD, Simon JF, Arrigain S, Tang A, Saab G et al (2013) Prognostic Importance of Serum Alkaline Phosphatase in CKD Stages 3-4 in a Clinical Population. Am J Kidney Dis 62(4):703\u201310. https:\/\/doi.org\/10.1053\/J.AJKD.2013.04.012","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"8035_CR23","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.2215\/CJN.01560309","volume":"4","author":"S Beddhu","year":"2009","unstructured":"Beddhu S, Ma X, Baird B, Cheung AK, Greene T (2009) Serum alkaline phosphatase and mortality in African Americans with chronic kidney disease. Clin J Am Soc Nephrol 4(11):1805\u20131810. https:\/\/doi.org\/10.2215\/CJN.01560309","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"8035_CR24","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1093\/NDT\/GFQ144","volume":"25","author":"CP Kovesdy","year":"2010","unstructured":"Kovesdy CP, Ureche V, Lu JL, Kalantar-Zadeh K (2010) Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD. Nephrol Dial Transplant 25(9):3003\u20133011. https:\/\/doi.org\/10.1093\/NDT\/GFQ144","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"8035_CR25","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/ndt\/gfw412","volume":"33","author":"K Sumida","year":"2018","unstructured":"Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Obi Y et al (2018) Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis. Nephrol Dial Transplant 33(2):264\u201373. https:\/\/doi.org\/10.1093\/ndt\/gfw412","journal-title":"Nephrol Dial Transplant"},{"key":"8035_CR26","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","volume":"7","author":"M Schmidt","year":"2015","unstructured":"Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, S\u00f8rensen HT (2015) The Danish National patient registry: a review of content, data quality, and research potential. Clin Epidemiol 7:449\u2013490. https:\/\/doi.org\/10.2147\/CLEP.S91125","journal-title":"Clin Epidemiol"},{"issue":"7","key":"8035_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1403494810387965","volume":"39","author":"CB Pedersen","year":"2011","unstructured":"Pedersen CB (2011) The Danish civil registration system. Scand J Public Health 39(7):22\u201325. https:\/\/doi.org\/10.1177\/1403494810387965","journal-title":"Scand J Public Health"},{"key":"8035_CR28","doi-asserted-by":"crossref","unstructured":"Schmidt M, Pedersen L, S\u00f8rensen HT (2014) The Danish Civil Registration System as a tool in epidemiology. European Journal of Epidemiology [Internet]. Report. Available from: https:\/\/www.jstor.org\/stable\/43775004","DOI":"10.1007\/s10654-014-9930-3"},{"key":"8035_CR29","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S245060","author":"JFH Arendt","year":"2020","unstructured":"Arendt JFH, Hansen AT, Ladefoged SA, S\u00f8rensen HT, Pedersen L, Adelborg K (2020) Existing data sources in clinical epidemiology: laboratory information system databases in Denmark. Clin Epidemiol. https:\/\/doi.org\/10.2147\/CLEP.S245060","journal-title":"Clin Epidemiol"},{"issue":"3","key":"8035_CR30","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/ije\/dyw213","volume":"46","author":"A Potteg\u00e5rd","year":"2017","unstructured":"Potteg\u00e5rd A, Schmidt SAJ, Wallach-Kildemoes H, S\u00f8rensen HT, Hallas J, Schmidt M (2017) Data resource profile: the Danish national prescription registry. Int J Epidemiol 46(3):798. https:\/\/doi.org\/10.1093\/ije\/dyw213","journal-title":"Int J Epidemiol"},{"key":"8035_CR31","doi-asserted-by":"publisher","unstructured":"Munch PV, Heide-J\u00f8rgensen U, Jensen SK, Birn H, Vestergaard SV, Fr\u00f8ki\u00e6r J et al (2023) Performance of the race-free CKD-EPI creatinine-based eGFR equation in a Danish cohort with measured GFR. Clin Kidney J 1(12):2728\u201337. https:\/\/doi.org\/10.1093\/ckj\/sfad253","DOI":"10.1093\/ckj\/sfad253"},{"key":"8035_CR32","doi-asserted-by":"publisher","unstructured":"Stevens PE, Levin A (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158(11):825\u2013830. https:\/\/doi.org\/10.7326\/0003-4819-158-11-201306040-00007","DOI":"10.7326\/0003-4819-158-11-201306040-00007"},{"issue":"7","key":"8035_CR33","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1177\/1403494809341095","volume":"37","author":"O Ekholm","year":"2009","unstructured":"Ekholm O, Hesse U, Davidsen M, Kj\u00f8ller M (2009) The study design and characteristics of the Danish national health interview surveys. Scand J Public Health 37(7):758\u2013765. https:\/\/doi.org\/10.1177\/1403494809341095","journal-title":"Scand J Public Health"},{"key":"8035_CR34","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2147\/CLEP.S407019","volume":"15","author":"AA Isaksen","year":"2023","unstructured":"Isaksen AA, Sandb\u00e6k A, Bjerg L (2023) Validation of register-based diabetes classifiers in Danish data. Clin Epidemiol 15:569\u2013581. https:\/\/doi.org\/10.2147\/CLEP.S407019","journal-title":"Clin Epidemiol"},{"key":"8035_CR35","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2147\/CLEP.S444447","volume":"16","author":"A Clausen","year":"2024","unstructured":"Clausen A, M\u00f6ller S, Skj\u00f8dt MK, Lynggaard RB, Vinholt PJ, Lindberg-Larsen M et al (2024) Validity of Major Osteoporotic Fracture Diagnoses in the Danish National Patient Registry. Clin Epidemiol 16:257\u201366. https:\/\/doi.org\/10.2147\/CLEP.S444447","journal-title":"Clin Epidemiol"},{"issue":"3","key":"8035_CR36","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/bimj.201800298","volume":"62","author":"BMH Ozenne","year":"2020","unstructured":"Ozenne BMH, Scheike TH, St\u00e6rk L, Gerds TA (2020) On the estimation of average treatment effects with right-censored time to event outcome and competing risks. Biom J 62(3):751\u2013763. https:\/\/doi.org\/10.1002\/bimj.201800298","journal-title":"Biom J"},{"key":"#cr-split#-8035_CR37.1","unstructured":"R core Team (2024) R: a language and environment for statistical computing [Internet]. Vienna, Austria"},{"key":"#cr-split#-8035_CR37.2","unstructured":"[cited 2025 Aug 20]. Available from: https:\/\/www.R-project.org\/"},{"key":"8035_CR38","doi-asserted-by":"publisher","unstructured":"Barrera-Baena P, Rodr\u00edguez-Garc\u00eda M, Rodr\u00edguez-Rubio E, Gonz\u00e1lez-Llorente L, Ortiz A, Zoccali C et al (2024) Serum phosphate is associated with increased risk of bone fragility fractures in haemodialysis patients. Nephrol Dial Transplant 39(4):618\u201326. https:\/\/doi.org\/10.1093\/ndt\/gfad190\u00a0","DOI":"10.1093\/ndt\/gfad190"},{"key":"8035_CR39","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/jbmr\/zjae021","volume":"23","author":"S Hsu","year":"2024","unstructured":"Hsu S, Bansal N, Denburg M, Ginsberg C, Hoofnagle AN, Isakova T et al (2024) Risk factors for hip and vertebral fractures in chronic kidney disease: the CRIC study. J Bone Miner Res 23:433\u201342. https:\/\/doi.org\/10.1093\/jbmr\/zjae021","journal-title":"J Bone Miner Res"},{"key":"8035_CR40","doi-asserted-by":"publisher","unstructured":"Maruyama Y, Nakashima A, Abe M, Hanafusa N, Nakai S, Yokoo T (2024) Higher serum alkaline phosphatase is risk for death and fracture a nationwide cohort study of Japanese dialysis patients. Kidney360.\u00a0https:\/\/doi.org\/10.34067\/KID.0000000656","DOI":"10.34067\/KID.0000000656"},{"key":"8035_CR41","doi-asserted-by":"publisher","unstructured":"Evenepoel P, Bover J, Ure\u00f1a Torres P, Elsevier BV (2016) Parathyroid hormone metabolism and signaling in health and chronic kidney disease. Kidney Int. https:\/\/doi.org\/10.1016\/j.kint.2016.06.041","DOI":"10.1016\/j.kint.2016.06.041"},{"key":"8035_CR42","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000992","author":"P Evenepoel","year":"2024","unstructured":"Evenepoel P, Skou H (2024) Skeletal parathyroid hormone hyporesponsiveness\u202f: a neglected, but clinically relevant reality in chronic kidney disease. Curr Opin Nephrol Hypertens. https:\/\/doi.org\/10.1097\/MNH.0000000000000992","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"8035_CR43","doi-asserted-by":"publisher","first-page":"740","DOI":"10.34067\/KID.0007382021","volume":"3","author":"NS Roetker","year":"2022","unstructured":"Roetker NS, Gilbertson DT, Weinhandl ED (2022) A brief introduction to competing risks in the context of kidney disease epidemiology. Kidney360 3(4):740\u2013743. https:\/\/doi.org\/10.34067\/KID.0007382021","journal-title":"Kidney360"},{"key":"8035_CR44","doi-asserted-by":"crossref","unstructured":"Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD (2003) Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney International. Report","DOI":"10.1046\/j.1523-1755.2003.00803.x"},{"issue":"1","key":"8035_CR45","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L et al (2017) Executive summary of the 2017 KDIGO Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD-MBD) guideline update: what\u2019s changed and why it matters. Kidney Int 92(1):26\u201336. https:\/\/doi.org\/10.1016\/j.kint.2017.04.006","journal-title":"Kidney Int"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08035-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08035-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08035-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:07:19Z","timestamp":1792271239000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08035-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["8035"],"URL":"https:\/\/doi.org\/10.1007\/s00198-026-08035-0","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"\u00a0The other authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HSJ declares a lecture fee from UCB (Union Chimique Belge) and travel support from UCB and Abiogen Pharma. DH reports a research grant from Vifor Pharma and Gedeon Richter and consultancy fees and lecture fees from UCB Nordic, GSK and Astra Zeneca.","order":2,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}}]}}